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E. coli is one of the major pathogenic bacteria that cause diarrhoea in human. Traditional fermented foods, e.g. Ogi, 
has been used indigenously to treat diarrhoea. This study was aimed at investigating the antagonistic activity of 
selected lactic acid bacteria (LAB) isolated from three varieties of ogi against multidrug resistant E. coli EKT004.
Antibiotic susceptibility of the tested E. coli EKT004 strain to ofl oxacin, gentamycin, cefuroxime, ceftazidine, 
lincomycin, oxacillin, cloxacillin, cefotaxime, ciprofl oxacin, and nitrofurantoin was tested by disc diffusion method. 
E. coli EKT004 was co-incubated in two different experiments with Weissella paramesenteroides, Lactobacillus 
plantarum, and L. fermentum that have been previously isolated from Ogi. An 8 h old E. coli was introduced into an 
overnight culture of LAB and a fresh E. coli was inoculated into overnight culture of LAB. Viable count of pathogen 
at 0 h and after 24 h co-incubation at 37 °C was observed.
The tested E. coli EKT004 was resistant to cefuroxime, ceftazidime, lincomycin, oxacillin, cloxacillin, and 
cefotaxime. The tested LAB isolates have a broad spectrum of activity against E. coli EKT004 used for the study 
with a decrease of 6–8 log of E. coli as compared with the control. These results indicate a direct effect of lactic acid 
bacterial strains on multidrug resistant E. coli strain.
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Most gastrointestinal tract diseases caused by bacterial pathogens or their toxins are spread 
through food or water. Transmission follows the faecal-oral route where contaminated food 
or water represents the vehicle for transmission. E. coli is one of the organisms most frequently 
isolated from different clinical cases of diarrhoea (OKEKE et al., 1999; TOBIH et al., 2006). 
Diarrhoea, which is an illness characterized by an increase in frequency and fl uidity of stools 
is one of the most common diseases causing infant death in developing countries 
(CHEESBROUGH, 1994; WALDERMAN, 1998). Diarrheal diseases continue to be a major cause of 
morbidity and mortality worldwide. The cornerstone of treatment recommended by the World 
Health Organization (WHO) remains the use of oral rehydration solution (ORS). As 
emphasized by GUANDALINI (2002), despite dramatic progresses in the understanding of the 
pathophysiology of diarrhoea, the list of drugs available is indeed short. The administration 
of antimicrobial agents, therapeutically or prophylactically, causes disturbances in the 
ecological balance between the host and the normal microbiota, leading to intestinal 
colonization by potentially pathogenic microorganisms and overgrowth by opportunistic 
microorganisms already present, followed by diarrhoea and fungal infections (SULLIVAN et al., 
2001).
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Furthermore, antimicrobial resistance has become a serious public health problem 
worldwide. Infections caused by resistant bacteria have been shown to be more frequently 
associated with increased morbidity and mortality than those caused by susceptible pathogens 
(HELMS et al., 2002; TRAVERS & BARZA, 2002). Some studies have already shown that E. coli 
often resist antibiotics such as ampicillin, amoxicillin-clavulanic acid, cotrimoxazole, 
nalidixic acid, and cephalothin (ALSHARA, 2011). Several factors result in increasing 
antimicrobial drug resistance rates in poor countries such as irrational antimicrobial drug 
usage and conditions of poor sanitation (OKEKE et al., 1999; BARTOLONI et al., 2006; TOBIH et 
al., 2006).
The addition of a medication to the WHO protocol for the treatment of acute diarrhoea 
in children is controversial. Recently, in addition to ORS, several new therapeutic strategies, 
including selected Lactobacillus strains and biotherapeutic agents containing selected, heat-
killed Lactobacillus strains, have demonstrated considerable potential for promoting a more 
rapid recovery from acute, watery diarrhoea by children with microbial enteritis (ISOLAURI et 
al., 2002).
Ogi is an acid fermented cereal gruel or porridge made from maize (Zea mays) or corn: 
sorghum (Sorghum vulgare) also known as guinea corn or millet (Pennisetum americanum) 
(OHENHEN & IKENEBOMEH, 2007). It is the most popular traditional health-sustaining fermented 
food in Western Nigeria, and serves as weaning foods for infants. In some communities in 
south-western Nigeria, Ogi is normally administered to people having gastroenteritis to 
minimize discomforts (ADERIYE & LALEYE, 2003; DAVID & FAMUREWA, 2010). Lactic acid 
bacteria have been directly involved in the fermentation of Ogi, but only minimal studies 
have shown their antimicrobial potential against gastrointestinal pathogens. Therefore, this 
study was carried out to evaluate the ability of LAB isolated from Ogi to prevent the growth 
of E. coli strain in co-culture.
1. Materials and methods
1.1. Microorganisms
Lactic acid bacterial strains have been previously isolated from Ogi, a Nigerian fermented 
cereal gruel, and identifi ed by partial sequencing of the 16S rRNA gene. Three of the identifi ed 
LAB strains were selected for co-culture studies based on their effi cient antagonistic 
properties. They are: Weissella paramesenteroides AFN004, Lactobacillus fermentum 
AFN018, and L. plantarum AFN021. Clinical strain of E. coli EKT004 isolated from 
gastrointestinal tract was collected from Medical Microbiology unit, Ekiti State University 
Teaching Hospital, Ado-Ekiti, Ekiti State Nigeria.
1.2. Antibiotic susceptibility of  E. coli EKT004
The susceptibility of E. coli EKT004 to various antibiotics was tested by disc diffusion 
method. The antibiotics used were ofl oxacin (30 μg), cefuroxime (30 μg), ceftazidine (30 
μg), lincomycin (30 μg), oxacillin (10 μg), cloxacillin (10 μg), augmentin (10 mg), cefotaxime 
(30 μg), ciprofl oxacin (30 μg), nitrofurantoin (100 μg), and gentamicin (30 μg). The 
susceptibility of the test organism to the used antibiotics was evident by clear zones of 
inhibition around the antibiotics disks, and the results were interpreted according to the 
guidelines of European Committee on Antimicrobial Susceptibility Testing (EUCAST, 2015).
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1.3. Co-culture of lactic acid bacteria and E. coli
The interference of LAB with the growth of pathogenic strains was evaluated by co-incubating 
Escherichia coli EKT004 individually with three representative strains of LAB (Weissella 
paramesenteroides AFN004, L. fermentum AFN018, L. plantarum AFN021) according to 
the modifi ed method of DRAGO and co-workers (1997). This was done in two series of 
experiments.
In the fi rst experiment, 1 ml of E. coli EKT004 corresponding to 2.96×1011 CFU ml–1 
was inoculated into 5 ml double strength nutrient broth, and then added to 5 ml of overnight 
culture of LAB and incubated for 24 h at 37 °C. The monoculture of the LAB and E. coli was 
evaluated at time zero (t0) by plating from an appropriate dilution factor onto MRS agar and 
MacConkey agar, respectively, followed by incubation at 37 °C for 24 h. Then, the mixture 
was serially diluted, and the appropriate dilution factor was plated accordingly to determine 
the colony counts of LAB and pathogen.
For the second experiment, both E. coli and the LAB were grown for 24 h at 37 °C. 
From the overnight culture of the pathogen corresponding to 2.96×1011 CFU ml–1 1 ml was 
inoculated into fresh nutrient broth and incubated for 8 h at 37 °C. After that the pathogen 
culture was centrifuged (for 10 min at 10 000 r.p.m.) and the supernatant discarded, then 5 ml 
of double strength nutrient broth was added to resuspend the pellet, vortexed, and added to 5 
ml of overnight culture of LAB making the whole mixture 10 ml. Serial dilution of both the 
pathogen alone (monoculture) and the mixture (co-culture) was done at 8 h, immediately 
after mixing, followed by plating out at appropriate dilutions. After 24 h incubation at 37 °C, 
appropriate serial dilutions of the mixture (co-culture) were plated on their respective 
selective media. Discrete colonies were counted and recorded.
2. Results and discussion
The menace of antibiotic resistance is a worldwide threat with accompanied therapeutic 
failure. This study reports the resistance of tested E. coli strain to 60% of tested antibiotics. 
The pathogen was resistant to lincomycin, oxacillin, cloxacillin, and ceftazidine. DENVER 
(2004) reported that amoxicillin and cloxacillin have no signifi cant activity against Gram-
negative pathogens and Pseudomonas aeruginosa. The test pathogen was also resistant to 
cefuroxime. Previous studies (OSTERBLAD et al., 1999; REDA et al., 2011) have shown that 
some pathogenic isolates from the Enterobacteriaceae family (Salmonella spp., Shigella 
spp., and E. coli) are resistant to cefuroxime, ampicillin, and amoxycillin/clavulanate. These 
results suggest that lincomycin, oxacillin, cloxacillin, ceftazidine, and cefuroxime should not 
be used in treating infections caused by pathogenic E. coli and other related diarrhoeagenic 
pathogens, as these pathogens have developed resistance to these antibiotics. The tested 
strain was sensitive to ofl oxacin, gentamycin, ciprofl oxacin, and nitrofurantoin. This result is 
in agreement with OSTERBLAD and co-workers (1999) and YISMAW and co-workers (2006), 
whose pathogenic isolates exhibited the least resistance to the above-named antibiotics.
In the present study we have shown that W. paramesenteroides AFN004, L. fermentum 
AFN018, and L. plantarum AFN021, which have been previously isolated from uncooked 
white Ogi (W. paramesenteroides AFN004, L. plantarum AFN021) and sorghum Ogi (L. 
fermentum AFN018), effectively inhibited the growth of E. coli EKT004, either when 
inoculated after 8 h and 24 h of growth of pathogen or when cultured overnight and then 
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incubated with the pathogens. In contrast, the growth of the LAB was not signifi cantly 
infl uenced by the presence of the pathogen (Figs 1–3).
Co-culture studies of overnight culture of W. paramesenteroides isolated from uncooked 
white Ogi showed that this LAB has a broad spectrum of activity against E. coli used for the 
study with a decrease of 6–8 log of the pathogen as compared with the control (Fig. 1). 
Previous studies (PAL & RAMANA, 2010) revealed that the purifi ed bacteriocin from W. 
paramesenteroides isolated from cucumber exhibited a broad inhibitory spectrum against 
foodborne pathogens and spoilage microorganisms, including Gram-negative bacteria such 
as Salmonella Typhimurium, Vibrio parahaemolyticus, Aeromonas hydrophila and Listeria 
monocytogenes. They also noted that in spite of various bacteriocins studied worldwide, 
studies on bacteriocins of Weissella paramesenteroides remain rare, hence the need to utilize 
the potentials of W. paramesenteroides isolated from Ogi as a probiotic. This study also 
emphasizes on the need to consume more of uncooked Ogi because of its probiotic benefi ts.
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Fig. 1. Inhibition of in vitro growth of E. coli EKT004 by W. paramesenteroides AFN004 in co-culture
: Control at 0 h; : control at 24 h; : co-culture at 24 h
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Fig. 2. Inhibition of in vitro growth of E. coli EKT004 by L. fermentum AFN018 in co-culture
: Control at 0 h; : control at 24 h; : co-culture at 24 h
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Co-culture studies of overnight culture of L. fermentum revealed that this LAB reduced 
the concentration of the cells of multidrug resistant E. coli by 6 log as compared to the control 
(Fig. 2). In the 8 h co-culture experiments, the concentration of E. coli cells decreased by 1 
log, while at 24 h, the concentration of E. coli cells decreased by 5 log as compared to the 
control (Figs 4–6). ALLAART and co-workers (2011) also reported that co-culturing of 
Clostridium perfringens with L. fermentum under in vitro conditions showed that, L. 
fermentum was capable of silencing beta2 toxin production of C. perfringens without 
infl uencing bacterial viability.
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Fig. 3. Inhibition of in vitro growth of E. coli EKT004 by L. plantarum AFN021 in co-culture
: Control at 0 h; : control at 24 h; : co-culture at 24 h
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Fig. 4. Antimicrobial activities of W. paramesenteroides AFN004 against 8 h grown E. coli EKT004 in co-culture
: Control; : co-cultured with W. paramesenteroides
This co-culture study also revealed and confi rmed the antagonistic activity of L. 
plantarum against E. coli. There was a 6 log reduction of the concentration of the pathogen 
cells when co-cultured with a 24-h culture (Fig. 3). This study was in agreement with previous 
studies by SZALA and co-workers (2012), where they reported that during two-day culture of 
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Salmonella Senftenberg and Lactobacillus plantarum strains No. 6 and 15 and L. brevis No. 
8, total inactivation of the pathogen was observed in all the tested mixed cultures with the 
largest decrease (in the count of Salmonella Senftenberg rods in mixed culture) between the 
16th and the 24th h of incubation, when the concentration of pathogen cells fell rapidly from 
values of 6 log to no detection level.
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Fig. 5. Antimicrobial activities of L. fermentum AFN018 against 8 h grown E. coli EKT004 in co-culture
: Control; : co-cultured with L. fermentum
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Fig. 6. Antimicrobial activities of L. plantarum AFN021 against 8 h grown E. coli EKT004 in co-culture
: Control; : co-cultured with L. plantarum
In the second co-culture experiment, at 8 h, the concentration of E. coli cells decreased 
by 3 log, while at 24 h, the concentration of E. coli cells decreased by 8 log as compared to 
the control (Figs 2, 5). ALAKOMI and co-workers (2000) reported that organic acids produced 
by LAB are the agents that inhibited the growth of Gram-negative bacteria such as E. coli and 
Salmonella sp.
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3. Conclusions
The presence of multidrug resistant E. coli strains has necessitated the search for other agents 
outside antibiotics that could reduce the population of the pathogen in the infectious site. This 
study shows that Weissella paramesenteroides, Lactobacillus plantarum, and L. fermentum 
naturally present in indigenous fermented Ogi reduced E. coli viable counts in co-culture and 
would have a great potential in inhibiting the growth of gastrointestinal E. coli when Ogi 
containing the tested LAB is consumed. This proves that the benefi cial bacteria present in 
indigenous fermented foods have antimicrobial properties against gastrointestinal pathogens.
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